Cargando…

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV

The aim of this study was to explore weight gain in people with HIV (PWH) at least 65 years of age who switch to a DTG based regimen (DTG-s) vs. remaining INSTI-naive (INSTI-n) on stable ART. METHODS: This was a longitudinal prospective study of PWH from the GEPPO cohort. At the beginning of the obs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guaraldi, Giovanni, Calza, Stefano, Milic, Jovana, Calcagno, Andrea, Focà, Emanuele, Rota, Matteo, Renzetti, Stefano, Celotti, Anna, Siano, Matteo, Celesia, Benedetto Maurizio, Piconi, Stefania, de Socio, Giuseppe Vittorio, Cattelan, Anna Maria, Orofino, Giancarlo, Riva, Agostino, Nozza, Silvia, di Perri, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Concise Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904432/ https://www.ncbi.nlm.nih.gov/pubmed/33635844 http://dx.doi.org/10.1097/QAD.0000000000002853

Ejemplares similares

Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort
por: Focà, Emanuele, et al.
Publicado: (2021)

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort
por: Focà, Emanuele, et al.
Publicado: (2019)

The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years
por: Guaraldi, G., et al.
Publicado: (2018)

Factors Associated With Weight Gain in People Treated With Dolutegravir
por: Taramasso, Lucia, et al.
Publicado: (2020)

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
por: Capetti, Amedeo F., et al.
Publicado: (2017)

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
por: Bagella, Paola, et al.
Publicado: (2019)

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort
por: Capetti, Amedeo F., et al.
Publicado: (2016)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort
por: Bonfanti, Paolo, et al.
Publicado: (2020)

COVID-19 incidence and mortality in Lombardy, Italy: An ecological study on the role of air pollution, meteorological factors, demographic and socioeconomic variables
por: De Angelis, Elena, et al.
Publicado: (2021)

The interplay of post-acute COVID-19 syndrome and aging: a biological, clinical and public health approach
por: Guaraldi, Giovanni, et al.
Publicado: (2022)

Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
por: Taramasso, Lucia, et al.
Publicado: (2022)

Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study
por: Cusato, Jessica, et al.
Publicado: (2022)

A weighted quantile sum regression with penalized weights and two indices
por: Renzetti, Stefano, et al.
Publicado: (2023)

Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy
por: Grayhack, Clara, et al.
Publicado: (2018)

Social attention and social-emotional modulation of attention in Angelman syndrome: an eye-tracking study
por: Micheletti, Serena, et al.
Publicado: (2023)

The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study
por: Guaraldi, Giovanni, et al.
Publicado: (2019)

The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2019)

Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study
por: D’Anna, Giulio, et al.
Publicado: (2023)

The Lisbon patient: exceptional longevity with HIV suggests healthy aging as an ultimate goal for HIV care
por: Pintassilgo, Ines, et al.
Publicado: (2020)

COVID-19 Aftermath: Exploring the Mental Health Emergency among Students at a Northern Italian University
por: Patrono, Alessandra, et al.
Publicado: (2022)

Psychological and Emotional Impact of COVID-19 Pandemic on People Living with Chronic Disease: HIV and Cancer
por: Focà, Emanuele, et al.
Publicado: (2022)

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project
por: Squillace, Nicola, et al.
Publicado: (2017)

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study
por: De Nicolò, Amedeo, et al.
Publicado: (2022)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapy
por: Huik, Kristi, et al.
Publicado: (2022)

Long-acting drugs: people’s expectations and physicians’ preparedness. Are we readying to manage it? An Italian survey
por: Celesia, Marta, et al.
Publicado: (2022)

Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study
por: Pennati, Francesca, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Frailty in older people living with HIV: current status and clinical management
por: Kehler, D. Scott, et al.
Publicado: (2022)

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir
por: Squillace, Nicola, et al.
Publicado: (2023)

Psychological Distress in Healthcare Workers between the First and Second COVID-19 Waves: The Role of Personality Traits, Attachment Style, and Metacognitive Functioning as Protective and Vulnerability Factors
por: Cena, Loredana, et al.
Publicado: (2021)

Estimating the Impact of the COVID-19 Pandemic on Maternal and Perinatal Health Care Services in Italy: Results of a Self-Administered Survey
por: Cena, Loredana, et al.
Publicado: (2021)

Mental Health States Experienced by Perinatal Healthcare Workers during COVID-19 Pandemic in Italy
por: Cena, Loredana, et al.
Publicado: (2021)

Imitation in Angelman syndrome: the role of social engagement
por: Micheletti, Serena, et al.
Publicado: (2020)

Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection
por: Sarteschi, Giovanni, et al.
Publicado: (2020)

Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
por: Bajetto, Adriana, et al.
Publicado: (2020)

Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis
por: Mazzitelli, Maria, et al.
Publicado: (2021)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_31bcsnfle1vklel5jfrb89hl7s